Arabinogalactan and lipoarabinomannan biosynthesis: Structure, biogenesis and their potential as drug targets

Future Microbiology

Volumn 7, Issue 1, 2012, Pages 129-147

  Jankute, Monika ^a   Grover, Shipra ^a   Rana, Amrita K ^a   Besra, Gurdyal S ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

arabinogalactan; biosynthesis; cell wall; ethambutol; lipoarabinomannan

Indexed keywords

ARABINOGALACTAN; BEDAQUILINE; BENZAMIDE DERIVATIVE; CLOFAZIMINE; DINITROBENZAMIDE; EBSELEN; ETHAMBUTOL; GALACTAN; GLYCOLIPID; ISONIAZID; LIPOARABINOMANNAN; MYCOLIC ACID; N (2 ADAMANTYL) N' GERANYLETHYLENEDIAMINE; PYRAZINAMIDE; RIFAMPICIN; UNCLASSIFIED DRUG;

BACTERIAL CELL WALL; BACTERIAL VIRULENCE; BIOGENESIS; BIOSYNTHESIS; CARBOHYDRATE ANALYSIS; CHEMICAL MODIFICATION; CLINICAL TRIAL (TOPIC); DRUG TARGETING; HUMAN; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHASE 1 CLINICAL TRIAL (TOPIC); POINT MUTATION; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; CELL WALL; GALACTANS; HUMANS; LIPOPOLYSACCHARIDES; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84555202687     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.123     Document Type: Review

References (146)

1. 1H nuclear magnetic resonance spectroscopy. Biochemistry 34(13), 4257-4266 (1995).
2. 13C NMR analyses. J. Biol. Chem. 265(12), 6734-6743 (1990).
3. Dover LG, Cerdeno-Tarraga AM, Pallen MJ, Parkhill J, Besra GS. Comparative cell wall core biosynthesis in the mycolated pathogens, Mycobacterium tuberculosis and Corynebacterium diphtheriae. FEMS Microbiol. Rev. 28(2), 225-250 (2004). (Pubitemid 38510503)
4. Kaur D, Guerin ME, Skovierova H, Brennan PJ, Jackson M. Chapter 2: Biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis. Adv. Appl. Microbiol. 69, 23-78 (2009).
5. McNeil M, Daffe M, Brennan PJ. Evidence for the nature of the link between the arabinogalactan and peptidoglycan of mycobacterial cell walls. J. Biol. Chem. 265(30), 18200-18206 (1990).
6. McNeil M, Daffe M, Brennan PJ. Location of the mycolyl ester substituents in the cell walls of mycobacteria. J. Biol. Chem. 266(20), 13217-13223 (1991). (Pubitemid 21907331)
7. Hoffmann C, Leis A, Niederweis M, Plitzko JM, Engelhardt H. Disclosure of the mycobacterial outer membrane: cryo-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc. Natl Acad. Sci. USA 105(10), 3963-3967 (2008). (Pubitemid 351723507)
8. Liu J, Rosenberg EY, Nikaido H. Fluidity of the lipid domain of cell wall from Mycobacterium chelonae. Proc. Natl Acad. Sci. USA 92(24), 11254-11258 (1995).
9. Mishra AK, Driessen NN, Appelmelk BJ, Besra GS. Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. FEMS Microbiol. Rev. 35(6), 1126-1157 (2011).
10. Jain A, Mondal R. Extensively drug-resistant tuberculosis: current challenges and threats. FEMS Immunol. Med. Microbiol. 53(2), 145-150 (2008). (Pubitemid 351832181)
11. Banerjee A, Dubnau E, Quemard A et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263(5144), 227-230 (1994). (Pubitemid 24067929)
12. Telenti A, Philipp WJ, Sreevatsan S et al. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat. Med. 3(5), 567-570 (1997). (Pubitemid 27198658)
13. McNeil M, Wallner SJ, Hunter SW, Brennan PJ. Demonstration that the galactosyl and arabinosyl residues in the cell-wall arabinogalactan of Mycobacterium leprae and Mycobacterium tuberculosis are furanoid. Carbohydr. Res. 166(2), 299-308 (1987).
14. Bhamidi S, Scherman MS, Rithner CD et al. The identifcation and location of succinyl residues and the characterization of the interior arabinan region allow for a model of the complete primary structure of Mycobacterium tuberculosis mycolyl arabinogalactan. J. Biol. Chem. 283(19), 12992-13000 (2008).
15. Alderwick LJ, Seidel M, Sahm H, Besra GS, Eggeling L. Identifcation of a novel arabinofuranosyltransferase (AftA) involved in cell wall arabinan biosynthesis in Mycobacterium tuberculosis. J. Biol. Chem. 281(23), 15653-15661 (2006). (Pubitemid 43848451)
16. Lee A, Wu SW, Scherman MS et al. Sequencing of oligoarabinosyl units released from mycobacterial arabinogalactan by endogenous arabinanase: identifcation of distinctive and novel structural motifs. Biochemistry 45(51), 15817-15828 (2006). (Pubitemid 46032502)
17. Draper P, Khoo KH, Chatterjee D, Dell A, Morris HR. Galactosamine in walls of slow-growing mycobacteria. Biochem. J. 327(Pt 2), 519-525 (1997). (Pubitemid 27477832)
18. Mikusova K, Mikus M, Besra GS, Hancock I, Brennan PJ. Biosynthesis of the linkage region of the mycobacterial cell wall. J. Biol. Chem. 271(13), 7820-7828 (1996). (Pubitemid 26107065)
19. Jin Y, Xin Y, Zhang W, Ma Y. Mycobacterium tuberculosis Rv1302 and Mycobacterium smegmatis MSMEG-4947 have WecA function and MSMEG-4947 is required for the growth of M. smegmatis. FEMS Microbiol. Lett. 310(1), 54-61 (2010).
20. Mills JA, Motichka K, Jucker M et al. Inactivation of the mycobacterial rhamnosyltransferase, which is needed for the formation of the arabinogalactan-peptidoglycan linker, leads to irreversible loss of viability. J. Biol. Chem. 279(42), 43540-43546 (2004). (Pubitemid 39390654)
21. Wu Q, Zhou P, Qian S et al. Cloning, expression, identifcation and bioinformatics analysis of Rv3265c gene from Mycobacterium tuberculosis in Escherichia coli. Asian Pac. J. Trop. Med. 4(4), 266-270 (2011).
22. Li W, Xin Y, Mcneil MR, Ma Y. rmlB and rmlC genes are essential for growth of mycobacteria. Biochem. Biophys. Res. Commun. 342(1), 170-178 (2006). (Pubitemid 43247373)
23. Ma Y, Pan F, Mcneil M. Formation of dTDP-rhamnose is essential for growth of mycobacteria. J. Bacteriol. 184(12), 3392-3395 (2002). (Pubitemid 34568950)
24. Kremer L, Dover LG, Morehouse C et al. Galactan biosynthesis in Mycobacterium tuberculosis. Identifcation of a bifunctional UDP- galactofuranosyltransferase. J. Biol. Chem. 276(28), 26430-26440 (2001).
25. Belanova M, Dianiskova P, Brennan PJ et al. Galactosyl transferases in mycobacterial cell wall synthesis. J. Bacteriol. 190(3), 1141-1145 (2008). (Pubitemid 351170959)
26. Szczepina MG, Zheng RB, Completo GC, Lowary TL, Pinto BM. STD-NMR studies of two acceptor substrates of GlfT2, a galactofuranosyltransferase from Mycobacterium tuberculosis: epitope mapping studies. Bioorg. Med. Chem. 18(14), 5123-5128 (2010).
27. Wolucka BA, McNeil MR, De Hoffmann E, Chojnacki T, Brennan PJ. Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria. J. Biol. Chem. 269(37), 23328-23335 (1994). (Pubitemid 24283325)
28. Alderwick LJ, Lloyd GS, Lloyd AJ, Lovering AL, Eggeling L, Besra GS. Biochemical characterization of the Mycobacterium tuberculosis phosphoribosyl-1-pyrophosphate synthetase. Glycobiology 21(4), 410-425 (2011).
29. Alderwick LJ, Radmacher E, Seidel M et al. Deletion of Cg-emb in corynebacterianeae leads to a novel truncated cell wall arabinogalactan, whereas inactivation of Cg-ubiA results in an arabinan-defcient mutant with a cell wall galactan core. J. Biol. Chem. 280(37), 32362-32371 (2005). (Pubitemid 41361846)
30. Tatituri RV, Alderwick LJ, Mishra AK et al. Structural characterization of a partially arabinosylated lipoarabinomannan variant isolated from a Corynebacterium glutamicum ubiA mutant. Microbiology 153(Pt 8), 2621-2629 (2007). (Pubitemid 47262051)
31. Jiang T, He L, Zhan Y et al. The effect of MSMEG-6402 gene disruption on the cell wall structure of Mycobacterium smegmatis. Microb. Pathog. 51(3), 156-160 (2011).
32. Meniche X, De Sousa-D'auria C, Van-Der-Rest B et al. Partial redundancy in the synthesis of the D-arabinose incorporated in the cell wall arabinan of Corynebacterineae. Microbiology 154(Pt 8), 2315-2326 (2008).
33. Crellin PK, Brammananth R, Coppel RL. Decaprenylphosphoryl-a-D-ribose 2́-epimerase, the target of benzothiazinones and dinitrobenzamides, is an essential enzyme in Mycobacterium smegmatis. PLoS ONE 6(2), e16869 (2011).
34. Shi L, Zhou R, Liu Z et al. Transfer of the frst arabinofuranose residue to galactan is essential for Mycobacterium smegmatis viability J. Bacteriol. 190(15), 5248-5255 (2008).
35. Escuyer VE, Lety MA, Torrelles JB et al. The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan. J. Biol. Chem. 276(52), 48854-48862 (2001).
36. Birch HL, Alderwick LJ, Appelmelk BJ et al. A truncated lipoglycan from mycobacteria with altered immunological properties. Proc. Natl Acad. Sci. USA 107(6), 2634-2639 (2010).
37. Birch HL, Alderwick LJ, Bhatt A et al. Biosynthesis of mycobacterial arabinogalactan: identifcation of a novel a(1→3) arabinofuranosyltransferase. Mol. Microbiol. 69(5), 1191-1206 (2008).
38. Zhang J, Angala SK, Pramanik PK et al. Reconstitution of functional mycobacterial arabinosyltransferase AftC proteoliposome and assessment of decaprenylphosphorylarabinose analogues as arabinofuranosyl donors. ACS Chem. Biol. 6(8), 819-828 (2011).
39. Skovierova H, Larrouy-Maumus G, Zhang J et al. AftD, a novel essential arabinofuranosyltransferase from mycobacteria. Glycobiology 19(11), 1235-1247 (2009).
40. Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Besra GS. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276(5317), 1420-1422 (1997). (Pubitemid 27235411)
41. Seidel M, Alderwick LJ, Birch HL, Sahm H, Eggeling L, Besra GS. Identifcation of a novel arabinofuranosyltransferase AftB involved in a terminal step of cell wall arabinan biosynthesis in Corynebacterianeae, such as Corynebacterium glutamicum and Mycobacterium tuberculosis. J. Biol. Chem. 282(20), 14729-14740 (2007). (Pubitemid 47093349)
42. Skovierova H, Larrouy-Maumus G, Pham H et al. Biosynthetic origin of the galactosamine substituent of arabinogalactan in Mycobacterium tuberculosis. J. Biol. Chem. 285(53), 41348-41355 (2010).
43. Scherman H, Kaur D, Pham H, Skovierova H, Jackson M, Brennan PJ. Identifcation of a polyprenylphosphomannosyl synthase involved in the synthesis of mycobacterial mannosides. J. Bacteriol. 191(21), 6769-6772 (2009).
44. Yagi T, Mahapatra S, Mikusova K, Crick DC, Brennan PJ. Polymerization of mycobacterial arabinogalactan and ligation to peptidoglycan. J. Biol. Chem. 278(29), 26497-26504 (2003). (Pubitemid 36876791)
45. Jackson M, Raynaud C, Laneelle MA et al. Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope. Mol. Microbiol. 31(5), 1573-1587 (1999). (Pubitemid 29110112)
46. Kacem R, De Sousa-D'auria C, Tropis M et al. Importance of mycoloyltransferases on the physiology of Corynebacterium glutamicum. Microbiology 150(Pt 1), 73-84 (2004). (Pubitemid 38111472)
47. Takayama K, Wang C, Besra GS. Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin. Microbiol. Rev. 18(1), 81-101 (2005). (Pubitemid 40170662)
48. Bhatt A, Molle V, Besra GS, Jacobs WR Jr, Kremer L. The Mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development. Mol. Microbiol. 64(6), 1442-1454 (2007). (Pubitemid 46900736)
49. De Souza MV, Ferreira Mde L, Pinheiro AC, Saraiva MF, De Almeida MV, Valle MS. Synthesis and biological aspects of mycolic acids: an important target against Mycobacterium tuberculosis. Scientifc World J. 8, 720-751 (2008).
50. Portevin D, De Sousa-D'auria C, Houssin C et al. A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms. Proc. Natl Acad. Sci. USA 101(1), 314-319 (2004). (Pubitemid 38084247)
51. Ballou CE, Vilkas E, Lederer E. Structural studies on the myo-inositol phospholipids of Mycobacterium tuberculosis (var. bovis, strain BCG). J. Biol. Chem. 238, 69-76 (1963).
52. Chatterjee D, Hunter SW, Mcneil M, Brennan PJ. Lipoarabinomannan. Multiglycosylated form of the mycobacterial mannosylphosphatidylinositols. J. Biol. Chem. 267(9), 6228-6233 (1992).
53. Severn WB, Furneaux RH, Falshaw R, Atkinson PH. Chemical and spectroscopic characterisation of the phosphatidylinositol manno- oligosaccharides from Mycobacterium bovis AN5 and WAg201 and Mycobacterium smegmatis mc2 155. Carbohydr. Res. 308(3-4), 397-408 (1998). (Pubitemid 28349983)
54. Khoo KH, Dell A, Morris HR, Brennan PJ, Chatterjee D. Structural defnition of acylated phosphatidylinositol mannosides from Mycobacterium tuberculosis: defnition of a common anchor for lipomannan and lipoarabinomannan. Glycobiology 5(1), 117-127 (1995).
55. Nigou J, Gilleron M, Puzo G. Lipoarabinomannans: characterization of the multiacylated forms of the phosphatidyl-myo-inositol anchor by NMR spectroscopy. Biochem. J. 337(Pt 3), 453-460 (1999).
56. Dinadayala P, Kaur D, Berg S et al. Genetic basis for the synthesis of the immunomodulatory mannose caps of lipoarabinomannan in Mycobacterium tuberculosis. J. Biol. Chem. 281(29), 20027-20035 (2006). (Pubitemid 44065777)
57. Chatterjee D, Bozic CM, McNeil M, Brennan PJ. Structural features of the arabinan component of the lipoarabinomannan of Mycobacterium tuberculosis. J. Biol. Chem. 266(15), 9652-9660 (1991). (Pubitemid 21906706)
58. Chatterjee D, Khoo KH, Mcneil MR, Dell A, Morris HR, Brennan PJ. Structural defnition of the non-reducing termini of mannose-capped LAM from Mycobacterium tuberculosis through selective enzymatic degradation and fast atom bombardment-mass spectrometry. Glycobiology 3(5), 497-506 (1993). (Pubitemid 23340110)
59. Khoo KH, Dell A, Morris HR, Brennan PJ, Chatterjee D. Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of mycobacterium. J. Biol. Chem. 270(21), 12380-12389 (1995).
60. Guerardel Y, Maes E, Elass E et al. Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae. Presence of unusual components with a 1,3-mannopyranose side chains. J. Biol. Chem. 277(34), 30635-30648 (2002). (Pubitemid 34970759)
61. Chatterjee D, Lowell K, Rivoire B, McNeil MR, Brennan PJ. Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains. J. Biol. Chem. 267(9), 6234-6239 (1992).
62. Vignal C, Guerardel Y, Kremer L et al. Lipomannans, but not lipoarabinomannans, purifed from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-a and IL-8 secretion by a CD14-toll-like receptor 2-dependent mechanism. J. Immunol. 171(4), 2014-2023 (2003). (Pubitemid 36966485)
63. Quesniaux VJ, Nicolle DM, Torres D et al. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinfammatory cytokines by mycobacterial lipomannans. J. Immunol. 172(7), 4425-4434 (2004). (Pubitemid 38375258)
64. + T-cell activation by interfering with proximal T-cell-receptor signaling. Infect. Immun. 77(10), 4574-4583 (2009).
65. 2+/calmodulin-PI3K hVPS34 cascade. J. Exp. Med. 198(4), 653-659 (2003). (Pubitemid 37040399)
66. Welin A, Winberg ME, Abdalla H et al. Incorporation of Mycobacterium tuberculosis lipoarabinomannan into macrophage membrane rafts is a prerequisite for the phagosomal maturation block. Infect. Immun. 76(7), 2882-2887 (2008).
67. Tse HM, Josephy SI, Chan ED, Fouts D, Cooper AM. Activation of the mitogen-activated protein kinase signaling pathway is instrumental in determining the ability of Mycobacterium avium to grow in murine macrophages. J. Immunol. 168(2), 825-833 (2002). (Pubitemid 34049584)
68. Garton NJ, Gilleron M, Brando T et al. A novel lipoarabinomannan from the equine pathogen Rhodococcus equi. Structure and effect on macrophage cytokine production. J. Biol. Chem. 277(35), 31722-31733 (2002). (Pubitemid 34968976)
69. Nigou J, Zelle-Rieser C, Gilleron M, Thurnher M, Puzo G. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. 166(12), 7477-7485 (2001). (Pubitemid 32525626)
70. Briken V, Porcelli SA, Besra GS, Kremer L. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol. Microbiol. 53(2), 391-403 (2004). (Pubitemid 38998163)
71. Besra GS, Brennan PJ. The mycobacterial cell wall: biosynthesis of arabinogalactan and lipoarabinomannan. Biochem. Soc. Trans. 25(3), 845-850 (1997). (Pubitemid 27416950)
72. Morita YS, Sena CB, Waller RF et al. PimE is a polyprenol-phosphate- mannose-dependent mannosyltransferase that transfers the ffth mannose of phosphatidylinositol mannoside in mycobacteria. J. Biol. Chem. 281(35), 25143-25155 (2006). (Pubitemid 44401901)
73. Kordulakova J, Gilleron M, Mikusova K et al. Defnition of the frst mannosylation step in phosphatidylinositol mannoside synthesis. PimA is essential for growth of mycobacteria. J. Biol. Chem. 277(35), 31335-31344 (2002). (Pubitemid 34968932)
74. Kordulakova J, Gilleron M, Puzo G et al. Identifcation of the required acyltransferase step in the biosynthesis of the phosphatidylinositol mannosides of mycobacterium species. J. Biol. Chem. 278(38), 36285-36295 (2003). (Pubitemid 37139953)
75. Bachhawat N, Mande SC. Identifcation of the INO1 gene of Mycobacterium tuberculosis H37Rv reveals a novel class of inositol-1-phosphate synthase enzyme. J. Mol. Biol. 291(3), 531-536 (1999). (Pubitemid 29392631)
76. Movahedzadeh F, Smith DA, Norman RA et al. The Mycobacterium tuberculosis ino1 gene is essential for growth and virulence. Mol. Microbiol. 51(4), 1003-1014 (2004). (Pubitemid 38270795)
77. Nigou J, Besra GS. Characterization and regulation of inositol monophosphatase activity in Mycobacterium smegmatis. Biochem. J. 361(Pt 2), 385-390 (2002). (Pubitemid 34174506)
78. Movahedzadeh F, Wheeler PR, Dinadayala P et al. Inositol monophosphate phosphatase genes of Mycobacterium tuberculosis. BMC Microbiol. 10, 50 (2010).
79. 2+. BMC Struct. Biol. 7, 55 (2007).
80. Jackson M, Crick DC, Brennan PJ. Phosphatidylinositol is an essential phospholipid of mycobacteria. J. Biol. Chem. 275(39), 30092-30099 (2000).
81. Guerin ME, Kordulakova J, Schaeffer F et al. Molecular recognition and interfacial catalysis by the essential phosphatidylinositol mannosyltransferase PimA from mycobacteria. J. Biol. Chem. 282(28), 20705-20714 (2007). (Pubitemid 47100006)
82. Mishra AK, Klein C, Gurcha SS et al. Structural characterization and functional properties of a novel lipomannan variant isolated from a Corynebacterium glutamicum pimB' mutant. Antonie Van Leeuwenhoek 94(2), 277-287 (2008).
83. Lea-Smith DJ, Martin KL, Pyke JS et al. Analysis of a new mannosyltransferase required for the synthesis of phosphatidylinositol mannosides and lipoarbinomannan reveals two lipomannan pools in corynebacterineae. J. Biol. Chem. 283(11), 6773-6782 (2008).
84. Guerin ME, Kaur D, Somashekar BS et al. New insights into the early steps of phosphatidylinositol mannoside biosynthesis in mycobacteria: PimB' is an essential enzyme of Mycobacterium smegmatis. J. Biol. Chem. 284(38), 25687-25696 (2009).
85. Schaeffer ML, Khoo KH, Besra GS et al. The pimB gene of Mycobacterium tuberculosis encodes a mannosyltransferase involved in lipoarabinomannan biosynthesis. J. Biol. Chem. 274(44), 31625-31631 (1999).
86. Torrelles JB, Desjardin LE, MacNeil J et al. Inactivation of Mycobacterium tuberculosis mannosyltransferase pimB reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death. Glycobiology 19(7), 743-755 (2009).
87. Mishra AK, Batt S, Krumbach K, Eggeling L, Besra GS. Characterization of the Corynebacterium glutamicum DpimB' DmgtA double deletion mutant and the role of Mycobacterium tuberculosis orthologues Rv2188c and Rv0557 in glycolipid biosynthesis. J. Bacteriol. 191(13), 4465-4472 (2009).
88. Tatituri RV, Illarionov PA, Dover LG et al. Inactivation of Corynebacterium glutamicum NCgl0452 and the role of MgtA in the biosynthesis of a novel mannosylated glycolipid involved in lipomannan biosynthesis. J. Biol. Chem. 282(7), 4561-4572 (2007). (Pubitemid 47100964)
89. Batt SM, Jabeen T, Mishra AK et al. Acceptor substrate discrimination in phosphatidyl-myo-inositol mannoside synthesis: structural and mutational analysis of mannosyltransferase Corynebacterium glutamicum PimB'. J. Biol. Chem. 285(48), 37741-37752 (2010).
90. Kremer L, Gurcha SS, Bifani P et al. Characterization of a putative a-mannosyltransferase involved in phosphatidylinositol trimannoside biosynthesis in Mycobacterium tuberculosis. Biochem. J. 363(Pt 3), 437-447 (2002). (Pubitemid 34526364)
91. Guerin ME, Kordulakova J, Alzari PM, Brennan PJ, Jackson M. Molecular basis of phosphatidyl-myo-inositol mannoside biosynthesis and regulation in mycobacteria. J. Biol. Chem. 285(44), 33577-33583 (2010).
92. Kovacevic S, Anderson D, Morita YS et al. Identifcation of a novel protein with a role in lipoarabinomannan biosynthesis in mycobacteria. J. Biol. Chem. 281(14), 9011-9017 (2006). (Pubitemid 43864613)
93. Crellin PK, Kovacevic S, Martin KL et al. Mutations in pimE restore lipoarabinomannan synthesis and growth in a Mycobacterium smegmatis lpqW mutant. J. Bacteriol. 190(10), 3690-3699 (2008).
94. Berg S, Kaur D, Jackson M, Brennan PJ. The glycosyltransferases of Mycobacterium tuberculosis-roles in the synthesis of arabinogalactan, lipoarabinomannan, and other glycoconjugates. Glycobiology 17(6), R35-R56 (2007).
95. Liu J, Mushegian A. Three monophyletic superfamilies account for the majority of the known glycosyltransferases. Protein Sci. 12(7), 1418-1431 (2003). (Pubitemid 36759346)
96. Mishra AK, Alderwick LJ, Rittmann D et al. Identifcation of a novel a(1→6) mannopyranosyltransferase MptB from Corynebacterium glutamicum by deletion of a conserved gene, NCgl1505, affords a lipomannan-and lipoarabinomannan-defcient mutant. Mol. Microbiol. 68(6), 1595-1613 (2008). (Pubitemid 351725269)
97. Kaur D, McNeil MR, Khoo KH et al. New insights into the biosynthesis of mycobacterial lipomannan arising from deletion of a conserved gene. J. Biol. Chem. 282(37), 27133-27140 (2007). (Pubitemid 47501909)
98. Mishra AK, Alderwick LJ, Rittmann D et al. Identifcation of an a(1→6) mannopyranosyltransferase (MptA), involved in Corynebacterium glutamicum lipomanann biosynthesis, and identifcation of its orthologue in Mycobacterium tuberculosis. Mol. Microbiol. 65(6), 1503-1517 (2007). (Pubitemid 47347833)
99. Mishra AK, Krumbach K, Rittmann D et al. Lipoarabinomannan biosynthesis in Corynebacterineae: the interplay of two a(1→2)- mannopyranosyltransferases MptC and MptD in mannan branching. Mol. Microbiol. 80(5), 1241-1259 (2011).
100. Sena CB, Fukuda T, Miyanagi K et al. Controlled expression of branch-forming mannosyltransferase is critical for mycobacterial lipoarabinomannan biosynthesis. J. Biol. Chem. 285(18), 13326-13336 (2010).
101. Shi L, Berg S, Lee A et al. The carboxy terminus of EmbC from Mycobacterium smegmatis mediates chain length extension of the arabinan in lipoarabinomannan. J. Biol. Chem. 281(28), 19512-19526 (2006). (Pubitemid 44035455)
102. Alderwick LJ, Lloyd GS, Ghadbane H et al. The C-terminal domain of the arabinosyltransferase Mycobacterium tuberculosis EmbC is a lectin-like carbohydrate binding module. PLoS Pathog. 7(2), E1001299 (2011).
103. Mishra AK, Batt SM, Alderwick LJ, Futterer K, Besra GS. Chapter 6: bacterial lipoarabinomannan: structure to biogenesis. In: Bacterial Glycomics: Current Reasearch, Technology and Applications. Reid CW (Ed.). Horizon Press, UK, 97-109 (2011).
104. Appelmelk BJ, Den Dunnen J, Driessen NN et al. The mannose cap of mycobacterial lipoarabinomannan does not dominate the mycobacterium-host interaction. Cell Microbiol. 10(4), 930-944 (2008). (Pubitemid 351386948)
105. Kilburn JO, Greenberg J. Effect of ethambutol on the viable cell count in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 11(3), 534-540 (1977). (Pubitemid 8065616)
106. Forbes M, Kuck NA, Peets EA. Effect of ethambutol on nucliec acid metabolism in Mycobacterium smegmatis and its reversal by polyamines and divalent cations. J. Bacteriol. 89, 1299-1305 (1965).
107. Kilburn JO, Takayama K, Armstrong EL, Greenberg J. Effects of ethambutol on phospholipid metabolism in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 19(2), 346-348 (1981). (Pubitemid 11157528)
108. Poso H, Paulin L, Brander E. Specifc inhibition of spermidine synthase from mycobacteria by ethambutol. Lancet 2(8364), 1418 (1983). (Pubitemid 14247702)
109. Silve G, Valero-Guillen P, Quemard A, Dupont MA, Daffe M, Laneelle G. Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug. Antimicrob. Agents Chemother. 37(7), 1536-1538 (1993). (Pubitemid 23202386)
110. Kilburn JO, Takayama K. Effects of ethambutol on accumulation and secretion of trehalose mycolates and free mycolic acid in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 20(3), 401-404 (1981). (Pubitemid 12225722)
111. Takayama K, Kilburn JO. Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 33(9), 1493-1499 (1989). (Pubitemid 19228001)
112. Deng L, Mikusova K, Robuck KG, Scherman M, Brennan PJ, McNeil MR. Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope. Antimicrob. Agents Chemother. 39(3), 694-701 (1995).
113. Belanger AE, Besra GS, Ford ME et al. The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc. Natl Acad. Sci. USA 93(21), 11919-11924 (1996). (Pubitemid 26347224)
114. Alcaide F, Pfyffer GE, Telenti A. Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob. Agents Chemother. 41(10), 2270-2273 (1997). (Pubitemid 27422225)
115. Lety MA, Nair S, Berche P, Escuyer V. A single point mutation in the embB gene is responsible for resistance to ethambutol in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 41(12), 2629-2633 (1997). (Pubitemid 27524732)
116. Starks AM, Gumusboga A, Plikaytis BB, Shinnick TM, Posey JE. Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 53(3), 1061-1066 (2009).
117. Hazbon MH, Bobadilla Del Valle M, Guerrero MI et al. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob. Agents Chemother. 49(9), 3794-3802 (2005). (Pubitemid 41233034)
118. Lee AS, Othman SN, Ho YM, Wong SY. Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48(11), 4447-4449 (2004). (Pubitemid 39434913)
119. Shen X, Shen GM, Wu J et al. Association between embB codon 306 mutations and drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 51(7), 2618-2620 (2007). (Pubitemid 47047350)
120. Saf H, Sayers B, Hazbon MH, Alland D. Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin. Antimicrob. Agents Chemother. 52(6), 2027-2034 (2008). (Pubitemid 351758539)
121. Ramaswamy SV, Amin AG, Goksel S et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 44(2), 326-336 (2000). (Pubitemid 30060727)
122. Zhang N, Torrelles JB, McNeil MR et al. The Emb proteins of mycobacteria direct arabinosylation of lipoarabinomannan and arabinogalactan via an N-terminal recognition region and a C-terminal synthetic region. Mol. Microbiol. 50(1), 69-76 (2003). (Pubitemid 37222787)
123. Amin AG, Goude R, Shi L, Zhang J, Chatterjee D, Parish T. EmbA is an essential arabinosyltransferase in Mycobacterium tuberculosis. Microbiology 154(Pt 1), 240-248 (2008). (Pubitemid 351201403)
124. Goude R, Amin AG, Chatterjee D, Parish T. The critical role of embC in Mycobacterium tuberculosis. J. Bacteriol. 190(12), 4335-4341 (2008). (Pubitemid 351812881)
125. Frieden TR, Driver CR. Tuberculosis control: past 10 years and future progress. Tuberculosis (Edinb.) 83(1-3), 82-85 (2003). (Pubitemid 36683554)
126. Zhang Y. The magic bullets and tuberculosis drug targets. Ann. Rev. Pharmacol. Toxicol. 45, 529-564 (2005). (Pubitemid 40261816)
127. Protopopova M, Hanrahan C, Nikonenko B et al. Identifcation of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines. J. Antimicrob. Chemother. 56(5), 968-974 (2005). (Pubitemid 41631930)
128. Prathipati P, Ma NL, Manjunatha UH, Bender A. Fishing the target of antitubercular compounds: in silico target deconvolution model development and validation. J. Proteome Res. 8(6), 2788-2798 (2009).
129. Jia L, Noker PE, Coward L, Gorman GS, Protopopova M, Tomaszewski JE. Interspecies pharmacokinetics and in vitro metabolism of SQ109. Br. J. Pharmacol. 147(5), 476-485 (2006). (Pubitemid 43355045)
130. Ginsberg AM. Drugs in development for tuberculosis. Drugs 70(17), 2201-2214.
131. Nikonenko BV, Protopopova M, Samala R, Einck L, Nacy CA. Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs. Antimicrob. Agents Chemother. 51(4), 1563-1565 (2007). (Pubitemid 46586854)
132. Reddy VM, Einck L, Andries K, Nacy CA. In vitro interactions between new antitubercular drug candidates SQ109 and TMC207 Antimicrob. Agents Chemother. 54(7), 2840-2846 (2010).
133. Makarov V, Riabova OB, Yuschenko A et al. Synthesis and antileprosy activity of some dialkyldithiocarbamates. J. Antimicrob. Chemother. 57(6), 1134-1138 (2006). (Pubitemid 44644416)
134. Makarov V, Manina G, Mikusova K et al. Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. Science 324(5928), 801-804 (2009).
135. Pasca MR, Degiacomi G, Ribeiro AL et al. Clinical isolates of Mycobacterium tuberculosis in four European hospitals are uniformly susceptible to benzothiazinones. Antimicrob. Agents Chemother. 54(4), 1616-1618 (2010).
136. Mikusova K, Huang H, Yagi T et al. Decaprenylphosphoryl arabinofuranose, the donor of the D-arabinofuranosyl residues of mycobacterial arabinan, is formed via a two-step epimerization of decaprenylphosphoryl ribose. J. Bacteriol. 187(23), 8020-8025 (2005). (Pubitemid 41691695)
137. Wolucka BA. Biosynthesis of D-arabinose in mycobacteria-a novel bacterial pathway with implications for antimycobacterial therapy. FEBS J. 275(11), 2691-2711 (2008). (Pubitemid 351678659)
138. Christophe T, Jackson M, Jeon HK et al. High content screening identifes decaprenyl-phosphoribose 2́ epimerase as a target for intracellular antimycobacterial inhibitors. PLoS Pathog. 5(10), E1000645 (2009).
139. Manina G, Bellinzoni M, Pasca MR et al. Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance. Mol. Microbiol. 77(5), 1172-1185 (2010).
140. Tangallapally R P, Yendapally R, Daniels AJ, Lee RE. Nitrofurans as novel anti-tuberculosis agents: identifcation, development and evaluation. Curr. Top Med. Chem. 7(5), 509-526 (2007). (Pubitemid 46488291)
141. Hurdle JG, Lee RB, Budha NR et al. A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents. J. Antimicrob. Chemother. 62(5), 1037-1045 (2008).
142. Grzegorzewicz AE, Ma Y, Jones V, Crick D, Liav A, McNeil MR. Development of a microtitre plate-based assay for lipid-linked glycosyltransferase products using the mycobacterial cell wall rhamnosyltransferase WbbL. Microbiology 154(Pt 12), 3724-3730 (2008).
143. Rose NL, Zheng RB, Pearacey J, Zhou R, Completo GC, Lowary TL. Development of a coupled spectrophotometric assay for GlfT2, a bifunctional mycobacterial galactofuranosyltransferase. Carbohydr. Res. 343(12), 2130-2139 (2008).
144. Umesiri FE, Sanki AK, Boucau J, Ronning DR, Sucheck SJ. Recent advances toward the inhibition of mAG and LAM synthesis in Mycobacterium tuberculosis. Med. Res. Rev. 30(2), 290-326 (2010).
145. Laurent N, Voglmeir J, Flitsch SL. Glycoarrays-tools for determining protein-carbohydrate interactions and glycoenzyme specifcity. Chem. Commun. (Camb.) 37, 4400-4412 (2008).
146. Blixt O. Glycoarrays. Editorial. Glycoconj. J. 25(1), 3-4 (2008).